# HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure

> **NCT02608632** · PHASE2 · UNKNOWN · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 170 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DEVICE:** Renal denervation guided by HFS
- **DEVICE:** Renal denervation as standard procedure

## Key facts

- **NCT ID:** NCT02608632
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2015-12
- **Final completion:** 2016-02
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2015-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02608632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02608632, "HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02608632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*